PAYX vs VYNE · P/E 22, rev $6.51B vs rev $501.0K
Paychex Inc (PAYX) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
PAYX currently screens at market cap $34.96B and trailing P/E 21.5. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the PAYX and VYNE stock pages for the full models.
Not investment advice.